MYRIAD GENETICS, INC. Proceeds from Lines of Credit
MYRIAD GENETICS, INC. (MYGN) reported Proceeds from Lines of Credit of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-07-31
- MYRIAD GENETICS, INC. proceeds from lines of credit for the quarter ending 2026-06-30 was $0.00.
- MYRIAD GENETICS, INC. proceeds from lines of credit for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. proceeds from lines of credit for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. proceeds from lines of credit for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. proceeds from lines of credit for fiscal 2025 was $40.00M, a 66.67% decline from fiscal 2024.
- MYRIAD GENETICS, INC. proceeds from lines of credit for fiscal 2024 was $120.00M, a 50.00% increase from fiscal 2023.
- MYRIAD GENETICS, INC. proceeds from lines of credit for fiscal 2023 was $80.00M.
- MYRIAD GENETICS, INC. proceeds from lines of credit for fiscal 2022 was $0.00.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $0.00 10-Q · filed 2026-07-31 | $0.00 derived: sum of 3 quarters · filed 2026-07-31 | $0.00 derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $0.00 derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-07-31 | $40.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-07-31 | $40.00M 10-Q · filed 2025-11-04 | $60.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $40.00M 10-Q · filed 2026-07-31 | $60.00M derived: sum of 3 quarters · filed 2026-07-31 | $80.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $40.00M 10-Q · filed 2026-05-06 | $60.00M derived: sum of 2 quarters · filed 2026-05-06 | $80.00M derived: sum of 3 quarters · filed 2026-05-06 | $100.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $40.00M derived: sum of 2 quarters · filed 2026-02-24 | $60.00M derived: sum of 3 quarters · filed 2026-02-24 | $120.00M 10-K · filed 2026-02-24 |
| 2024-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $40.00M derived: sum of 2 quarters · filed 2025-11-04 | $100.00M 10-Q · filed 2025-11-04 | $140.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $80.00M 10-Q · filed 2025-08-06 | $120.00M derived: sum of 3 quarters · filed 2026-02-24 | $120.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $60.00M 10-Q · filed 2025-05-07 | $100.00M derived: sum of 2 quarters · filed 2026-02-24 | $100.00M derived: sum of 3 quarters · filed 2026-02-24 | $140.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $40.00M derived: sum of 2 quarters · filed 2026-02-24 | $80.00M derived: sum of 3 quarters · filed 2026-02-24 | $80.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $40.00M derived: sum of 2 quarters · filed 2024-11-08 | $40.00M 10-Q · filed 2024-11-08 | $40.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $40.00M 10-Q · filed 2024-08-07 | $40.00M derived: sum of 3 quarters · filed 2025-02-28 | $40.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2020-06-30 | $0.00 10-K · filed 2022-02-25 | |||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $50.00M derived: sum of 3 quarters · filed 2022-02-25 | $340.00M 10-K · filed 2022-02-25 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-06 | $50.00M derived: sum of 2 quarters · filed 2020-05-06 | $340.00M 10-Q · filed 2020-05-06 | $340.00M derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-07 | $340.00M 10-Q · filed 2020-02-07 | $340.00M derived: sum of 3 quarters · filed 2021-03-16 | |
| 2018-09-30 | $290.00M 10-Q · filed 2019-11-06 | $290.00M derived: sum of 2 quarters · filed 2021-03-16 | ||
| 2018-06-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2021-03-16 | $53.00M 10-KT · filed 2021-03-16 | ||
| 2018-03-31 | $53.00M 10-Q · filed 2019-05-08 | |||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $0.00 derived: sum of 2 quarters · filed 2019-08-13 | $204.00M 10-K · filed 2019-08-13 | |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $204.00M 10-Q · filed 2018-05-09 | ||
| 2016-12-31 | $204.00M 10-Q · filed 2018-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |